Life Technologies extends partnershpi with DNAVEC

theflyonthewall.com

Life Technologies has extended its collaborative agreement with Japanese firm DNAVEC Corporation to launch CytoTune-iPS 2.0 Sendai Reprogramming Kit, the next-generation research technology that enables the most efficient method to develop induced pluripotent stem cells from human somatic cells. By extending its collaborative research agreement with DNAVEC Corp., Life Technologies plans to build on the success it's forged through the broad adoption of the CytoTune technology. Under the agreement, DNAVEC will undertake early stage R&D to apply its Sendai virus technology to third- and fourth-generation tools for use within the reprogramming and stem-cell workflows.

Rates

View Comments (0)